COA Warns That Price Negotiation for Medicare Part B Drugs Threatens Community Oncology
CancerNetwork · 1 hour ago
The Community Oncology Alliance is urging CMS and Congress to address Medicare Part B drug negotiation policies that threaten independent cancer practices and patient access.
Continue reading at CancerNetwork →
Related Reading
- MatrixCare Speeds Up Post-Acute Strategy Under New CEO Jonathan Lujan · Home Health Care News · 1m ago
- Fire Crews Rescue Eight from Blaze at Assisted Living Facility · Outlook Newspapers · 33m ago
- Cline Architecture Firm Appoints Senior Housing Sector Director In Raleigh, North Carolina · EFA Magazine · 43m ago
- Medicare Mondays with Mackenzie: Making sense of dental, vision and hearing coverage · cbsaustin.com · 50m ago